Early discontinuation of anti-seizure medications in neonates with hypoxic-ischemic encephalopathy
Autor: | Nicholas S. Abend, Mark Fitzgerald, Sudha Kilaru Kessler |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Male
Encephalopathy Electroencephalography Hypoxic Ischemic Encephalopathy Article Cohort Studies 03 medical and health sciences 0302 clinical medicine Interquartile range Hypothermia Induced Recurrence 030225 pediatrics Intensive Care Units Neonatal medicine Humans Monitoring Physiologic Retrospective Studies Likelihood Functions medicine.diagnostic_test business.industry Infant Newborn Infant Symptomatic seizures Retrospective cohort study respiratory system Hypothermia medicine.disease Magnetic Resonance Imaging Patient Discharge Discontinuation Neurology Anesthesia Child Preschool Hypoxia-Ischemia Brain Anticonvulsants Female Neurology (clinical) Epilepsies Partial medicine.symptom business 030217 neurology & neurosurgery Follow-Up Studies |
Popis: | SummaryObjective Neonates with hypoxic–ischemic encephalopathy (HIE) managed with therapeutic hypothermia (TH) often experience acute symptomatic seizures, prompting treatment with antiseizure medications (ASMs). Because the risk of seizure occurrence after hospital discharge is unknown, the optimal ASM treatment duration is unclear. We aimed to determine the risk of seizure occurrence after hospital discharge and the impact of ASM treatment duration on this outcome. Methods We performed a single-center, retrospective study of consecutive neonates with HIE managed with TH who received ASMs for acute symptomatic seizures from June 2010 through December 2014. Neonates were monitored with continuous electroencephalography (EEG) during TH. Results Follow-up data were available for 59 (82%) of 72 neonates who survived to discharge, with a median follow-up period of 19 months (interquartile range [IQR] 11–25). Acute symptomatic seizures occurred in 35 neonates (59%), including electrographic seizures in 21 neonates (36%). ASMs were continued upon discharge in 17 (49%) of 35 neonates. Seizures occurred in follow-up in four neonates (11%). No patient for whom ASMs were discontinued prior to discharge experienced seizures during the follow-up period. Significance Among neonates with HIE, seizures after hospital discharge were rare in those with acute symptomatic seizures and did not occur in neonates without acute symptomatic seizures. ASM discontinuation prior to discharge did not increase the risk of seizures during the follow-up period, suggesting that ASMs may be discontinued in many neonates prior to discharge. |
Databáze: | OpenAIRE |
Externí odkaz: |